1 / 3

Antibiotics Market Size, Application, Development, Business-Growth & Forecast 2024

The global antibiotics market is likely to grow at a significant CAGR in the forecast period. Antibiotics are medicinal drugs that completely eliminate the other bacteria whereas some prevent the growth. The ones that kill bacteria could be termed as bactericidal while those inhibiting the growth are inferred as bacteriostatic. Antibiotics are commonly referred to as antibacterial antibiotic compounds and differentiated as antifungals, antibacterial, and antivirals; revealing their identity as microorganisms.<br>

4769
Download Presentation

Antibiotics Market Size, Application, Development, Business-Growth & Forecast 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antibiotics Market Size & Forecast Report, 2013 - 2024 “The global antibiotics market is likely to grow at a significant CAGR in the forecast period. Antibiotics are medicinal drugs that completely eliminate the other bacteria whereas some prevent the growth. The ones that kill bacteria could be termed as bactericidal while those inhibiting the growth are inferred as bacteriostatic. The global antibiotics market is likely to grow at a significant CAGR in the forecast period. Antibiotics are medicinal drugs that completely eliminate the other bacteria whereas some prevent the growth. The ones that kill bacteria could be termed as bactericidal while those inhibiting the growth are inferred as bacteriostatic. Antibiotics are commonly referred to as antibacterial antibiotic compounds and differentiated as antifungals, antibacterial, and antivirals; revealing their identity as microorganisms. Antibiotics market is significantly driven by increase in research & development by pharmaceutical companies from the developing nations. Production of generic drugs has played a significant role in development of antibiotics. Production of antibiotic drugs comprises generic medicines especially for the low-income group in the major countries. Additionally, generic industries have played a significant role in shaping the pharmaceutical industry at a regional level. Request a Free Sample Copy @ https://www.millioninsights.com/industry-reports/antibiotics- market-size/request-sample By class, the antibiotics market segmentation includes quinolones, sulfinoamides, tetracyclines, aminoglycosides, phenicols, and beta lactams. Beta lactams dominated the market scenario in the recent past. Geographical segmentation for antibiotic market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. Asia-Pacific is projected to rise at a significant CAGR in the forthcoming period owing to presence of medical institutions, manufacturing setups, and a wide availability of patient pool. North American and European markets are likely to gain a significant growth in the forecast period owing to rise in mortality due to pneumonia, tuberculosis, and moderate availability of antibiotics. The rise in number of contagious diseases is likely to drive the demand for antibiotics. MEA market is likely to gain a significant share in the forecast period owing to rise in prevalence of contagious disease and demand for medical drugs.

  2. The key players in the antibiotics industry include Pfizer, Inc., Abbott Laboratories, GlaxoSmithKline PLC, Daiichii Sankyo Company Limited, Bayer HealthCare Pharmaceuticals LLC, Astellas Pharma, Inc., Merck & Company Inc., Roche Holding AG, Bristol-Myers Squibb Co., Cubist Pharmaceuticals, Inc., GlaxoSmithKline Plc, Pliva, Toyama Chemical Co. Ltd. and Takeda Pharmaceutical Company. Ltd., Johnson & Johnson, LG Life Sciences Limited, and Eli Lilly. Browse Report Summary with TOC @ https://www.millioninsights.com/industry- reports/antibiotics-market-size Market Segment: Global Antibiotics Drug Class Outlook (Revenue, USD Million, 2013 - 2024) • Cephalosporins • Penicillins • Fluoroquinolones • Macrolides • Carbapenems • Aminoglycosides • Sulfonamides • Other Global Mechanism Outlook (Revenue, USD Million, 2013 - 2024) • Cell Wall Synthesis Inhibitors • Protein Synthesis Inhibitors • DNA Synthesis Inhibitors • RNA Synthesis Inhibitors • Mycolic Acid Inhibitors Antibiotics Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • U.S. • Canada • Europe • UK • Germany • Asia Pacific • Japan • China • India • Latin America • Brazil • Mexico • MEA • South Africa

  3. Find More Category Reports @ https://www.millioninsights.com/industry/pharmaceuticals Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184

More Related